Acquired Angioedema

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-02-25
Clinical Trial Update: Lanadelumab in Long-term Prophylaxis of Acquired Angioedema [Phase 4]
A Phase 4 trial is evaluating lanadelumab for long-term prophylaxis of acquired angioedema, with recruitment ongoing.